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Ideally vectors for gene transfer in the brain should have the following characteristics: they should not incur any safety risks (neither infectious, nor toxic), they should be easy to produce and verify, they should not limit the size of genes to be vectorised and they should be able to transduce post-mitotic neurons. Non-viral vectors can potentially fulfil all of these criteria. [2] [3] [4] [5] [6] [7] In particular the branched cationic polymer polyethylenimine (PEI) has already been shown to be a versatile and efficient vector in the mammalian brain. 4, 8 So far the best results with PEI in vivo have been obtained with the lowest molecular weight preparation commercially available, In this study, we chose to examine the effect of formulation procedures (glucose or saline solutions) on the size and in vivo transfection activity of a mixture of linear polymers (repeated units of CH 2 -CH 2 -NH) with a mean MW of 22 kDa (Exgene 500; Euromedex, Souffleweyersheim, France). As the complexes formed in glucose were shown to be an order of magnitude smaller than those formed in saline, we examined the diffusibility and gene transfer efficiency of these complexes following injection into the cerebrospinal fluid. Indeed, expression of therapeutic genes in cells near the ventricular spaces of the brain could be useful for producing growth factors or analgesic peptides or for applying gene therapy of leptomeningeal carcinomas. Such approaches have been tested with adenoviral 9 and retroviral 10 vectors, but not with synthetic vectors. PEI/DNA complexes with different ratios of PEI nitrogen to DNA phosphate (N/P ratio) were prepared in either 5% glucose or 150 mm NaCl using a CMV-Luc plasmid 8 and the 22 kDa linear PEI. This PEI is synthesised to a degree of polymerisation (DP) of 510 units. As seen in Figure 1a , when working with this PEI at a ratio of 2 PEI nitrogens per phosphate (2 N/P) the large majority of particles formed in glucose had diameters of approximately 100 nm, whereas most of the complexes formed in NaCl at the same N/P ratio had diameters of 
PEI). After 10 to 20 min, particle size was determined by quasi-elastic light scattering (QUELS) on a Zetamasters 3 (Malvern Instruments, Orsay, France). (d-e) Electron micrographs of PEI 22 kDa/DNA complexes prepared in NaCl 0.15 m (d, N/P = 2) or in 5% (w/w) glucose (e, N/P = 5). Briefly, a drop of complexes prepared as stated above was added on a carbon covered grid that was freshly glow-discharged. After 1 min, excess of liquid was removed and complexes were stained with 30 l of uranyl acetate (1% w/v). Observation was carried out at 80 kV under a Philips (Eindhoven, The Netherlands) EM410 electron microscope. Bars are 100 nm.
over 1 m. What is more, these PEI/DNA particles formed at a N/P of 2 in either NaCl or glucose tended to release their DNA under stringent conditions such as high ionic strength or competition with charged surfaces (P Erbacher, unpublished observations). Increasing the N/P ratio to 6 or 10 decreased the size of particles formulated in glucose. More than 60% of the particles had diameters of 50 to 60 nm and this size was reproducible over a wide range of DNA concentrations (10 to 500 g/ml). However, a similar increase in N/P ratio had no effect on particles formulated in NaCl (Figure 1b and c) . Carrying out electron microscopy on particles formed in either NaCl or glucose confirmed these findings. Particles formed in NaCl were clumped and of highly irregular shape (Figure 1d ), whereas complexes produced in glucose were discrete spheres or toroids (Figure 1e) . Again, size measurement showed particles to have a mean size (diameter or length) of 37 ± 26 nm (n = 83) with very few particles in oligomeric structures.
To determine the spatial distribution of transgenes introduced into the developing and the adult brain we used a plasmid containing the coding sequence of ␤-galactosidase (lacZ) under the CMV promoter or the same CMV-luciferase plasmid as used for biophysical measurements. These plasmids were of similar size. Newborn and adult mice were injected respectively with a single injection (2 or 5 l of a 5% glucose solution containing 0.5 g/l of DNA) into one or both of the lateral ventricles. In both cases the DNA was complexed with 22 kDa PEI at a N/P ratio of 6, as this ratio gave optimal results in quantitative assays with luciferase as a reporter gene. The mice were killed 24 and 48 h later for newborns and Figure 2 . adults, respectively. Brains were dissected out and prepared for lacZ revelation, either by whole-mount staining for immature brain, and histochemistry or immunocytochemistry on vibratome sections for mature brains. After clarification of the newborn brains most labelled cells were found to be in the olfactory bulb and the lateral ventricle (Figures 2 a-d) . This wide distribution with transgene expression found up to 8 mm from the site of injection underlines the large diffusibility of the complexes in the developing nervous system. In the adult, diffusion was even more widespread. Examination of sections from adult brains, injected into one of the lateral ventricles, showed sections with positive cells ranging from the most anterior part of the brain (Figure 2e ) through the mid-brain (Figure 2f ) to the mammillary recess of the third ventricule (Figure 2g ). Within each section, numerous groups of lacZ-positive cells near the ventricular spaces were found. Thus particles diffused from one lateral ventricle to the other and were distributed throughout both sides of the brain over distances of up to 1.5 cm. In the course of these experiments 20 adult mice were injected with CMV-␤-gal/22 kDa PEI and ␤-galactosidase expression examined either on whole mounts or on sections. Transgene expression was found in all the injected brains, underlining the high reproducibility of the method. Moreover, in those brains examined by histochemistry on vibratome sections, at least 10 labelled cells were found in each section from the olfactory cortex to cerebellum and sometimes labelling was found in the brain stem. However, no labelling was found in the spinal cord.
Figure 3 Following intraventricular injection, transgene expression is found in both neuronal and glial cells bordering the ventricular space. Typical sections show lacZ (a, insert, b, c) and luciferase (e) expressing cells, and cell markers for neurons NeuN (d) or astrocytes GFAP (f). Small arrows denote the cells and processes positive for both labels. Histochemistry (a): vibratome sections were treated as in
To characterise the cells expressing the transgenes, we employed double immunochemistry on four of the injected brains using either a polyclonal antibody against ␤-galactosidase (Capell; Organon Tetrika, West Chester, PA, USA) or a polyclonal antibody against luciferase (Promega, Lyon, France). To determine the types of cells expressing the transgenes the appropriate transgenedirected antibody was mixed with either a monoclonal anti-NeuN antibody (Chemicon International, Temecula, CA, USA) to identify neurons 11 or a monoclonal anti-glial fibrillary acidic protein (GFAP; Dako, Glostrup, Denmark) to identify astrocytes. Cell marker antibodies were labelled directly with a fluorescent dye, Cy-3.5 (Fluorolink-AbTM), according to the manufacturer's instructions (Amersham, Les Ulis, France) and transgenedirected antibodies were revealed by fluorescent labelled anti-rabbit antibodies (Sigma, St Quentin, France). Transgene expression was found in each of the brains examined in both neurons (Figure 3c and d) and astrocytes (Figure 3e and f) near the ventricular walls. Controls included uninjected brains, brains injected with an irrelevant plasmid complexed with DNA and immunocytochemistry performed when omitting primary or secondary antibodies. All controls were negative and there was no background staining at the antibody concentrations used (see legend to Figure 3) .
No doubt the large diffusibility of these complexes formulated in glucose is related to their small size and stability. Indeed, EM studies show the particles to remain discrete up to 24 h after formulation. This extended stability, reflected by resistance to clumping, is not shared by 22 kDa PEI/DNA particles formed in NaCl, nor is it shared by particles formed by most other cationic vectors. This resistance to aggregation shown in glucose (with no ionic strength) is due to high repulsion between cationic particles which prevents their collapse. This repulsion is weakened in physiological conditions. Also 22 kDa PEI/CMV-luciferase particles formed in NaCl were one order of magnitude less effective in transfection in the newborn brain than those formed in glucose (4 ± 0.16 10 7 light units per microgramme DNA after complexation in glucose versus 4.5 ± 0.5 10 6 light units per microgramme DNA after complexation in NaCl ±s.e.m., n= 10 in each group).
In a recent report, Dunlap et al 12 used scanning force microscopy to examine DNA/lipospermines or DNA/PEI (22 or 25 kDa) complexes in low salt (15 mm NaCl) conditions. These authors found, as did Tang and Szoka 13 using branched 25 kDa PEI, that the complexes were small (Ͻ100 nm in both cases). The results of Dunlap et al showing small complexes formed with the 22 kDa PEI in salt solution differ from our data presented here. A possible explanation is the lower salt conditions used by Dunlap and co-authors 12 to examine the particles. However, in neither report 12, 13 did the authors test transfection performance in vivo nor in physiological fluids.
Like Tang and Szoka 13 we have also found that complexes formed with 25 kDa PEI are of small size in NaCl. Yet, there must be some biophysical differences in complexes formed with 25 kDa PEI in NaCl versus those formed with linear PEI in glucose, even if they have similar sizes. Indeed CMV-luc complexed with 25 kDa PEI in NaCl and transfected at optimal N/P ratios in newborn brains gives levels of expression one order of magnitude lower than the same DNA with linear PEI in glucose (data not shown).
We conclude that, if used in adequate conditions, not only are the particles formed with the linear 22 kDa polymer stable and highly diffusible, but they are also efficient for gene transfer. This is shown by the introduction of genes via intraventricular route, into neurons and glia of the mature and immature mammalian brain in vivo with no toxicity in either model. Applications of this technique will be found in the study of CNS function and in therapies of inherited or acquired brain disease.
